Cite
HARVARD Citation
Kim, K. et al. (2021). Outcomes of TP53‐mutant acute myeloid leukemia with decitabine and venetoclax. Cancer. 127 (20), pp. 3772-3781. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kim, K. et al. (2021). Outcomes of TP53‐mutant acute myeloid leukemia with decitabine and venetoclax. Cancer. 127 (20), pp. 3772-3781. [Online].